Structural parameterization of the binding enthalpy of small ligands

A major goal in ligand and drug design is the optimization of the binding affinity of selected lead molecules. However, the binding affinity is defined by the free energy of binding, which, in turn, is determined by the enthalpy and entropy changes. Because the binding enthalpy is the term that predominantly reflects the strength of the interactions of the ligand with its target relative to those with the solvent, it is desirable to develop ways of predicting enthalpy changes from structural considerations. The application of structure/enthalpy correlations derived from protein stability data has yielded inconsistent results when applied to small ligands of pharmaceutical interest (MW < 800). Here we present a first attempt at an empirical parameterization of the binding enthalpy for small ligands in terms of structural information. We find that at least three terms need to be considered: (1) the intrinsic enthalpy change that reflects the nature of the interactions between ligand, target, and solvent; (2) the enthalpy associated with any possible conformational change in the protein or ligand upon binding; and, (3) the enthalpy associated with protonation/deprotonation events, if present. As in the case of protein stability, the intrinsic binding enthalpy scales with changes in solvent accessible surface areas. However, an accurate estimation of the intrinsic binding enthalpy requires explicit consideration of long‐lived water molecules at the binding interface. The best statistical structure/enthalpy correlation is obtained when buried water molecules within 5–7 Å of the ligand are included in the calculations. For all seven protein systems considered (HIV‐1 protease, dihydrodipicolinate reductase, Rnase T1, streptavidin, pp60c‐Src SH2 domain, Hsp90 molecular chaperone, and bovine β‐trypsin) the binding enthalpy of 25 small molecular weight peptide and nonpeptide ligands can be accounted for with a standard error of ±0.3 kcal · mol−1. Proteins 2002;49:181–190. © 2002 Wiley‐Liss, Inc.

[1]  B. Lee,et al.  The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.

[2]  K. P. Murphy,et al.  Structural energetics of protein folding and binding. , 2000, Current opinion in biotechnology.

[3]  A. Velázquez‐Campoy,et al.  The binding energetics of first- and second-generation HIV-1 protease inhibitors: implications for drug design. , 2001, Archives of biochemistry and biophysics.

[4]  T. Bhat,et al.  Bound Water Molecules at the Interface between the HIV-1 Protease and a Potent Inhibitor, KNI-272, Determined by NMR , 1996 .

[5]  L. Pearl,et al.  Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. , 1999, Journal of medicinal chemistry.

[6]  R M Jackson,et al.  Comparison of binding energies of SrcSH2‐phosphotyrosyl peptides with structure‐based prediction using surface area based empirical parameterization , 2000, Protein science : a publication of the Protein Society.

[7]  B. Braden,et al.  Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface. , 2000, Biochemistry.

[8]  Andrew D. Robertson,et al.  Protein Structure and the Energetics of Protein Stability. , 1997, Chemical reviews.

[9]  D. Xie,et al.  Molecular basis of cooperativity in protein folding. V. Thermodynamic and structural conditions for the stabilization of compact denatured states , 1994, Proteins.

[10]  V. Hilser,et al.  The enthalpy change in protein folding and binding: Refinement of parameters for structure‐based calculations , 1996, Proteins.

[11]  J. J. Wendoloski,et al.  Crystallographic and thermodynamic comparison of natural and synthetic ligands bound to streptavidin , 1992 .

[12]  P. Weber,et al.  Crystallographic and thermodynamic comparison of structurally diverse molecules binding to streptavidin. , 1995, Acta crystallographica. Section D, Biological crystallography.

[13]  G. Scapin,et al.  Interaction of pyridine nucleotide substrates with Escherichia coli dihydrodipicolinate reductase: thermodynamic and structural analysis of binary complexes. , 1996, Biochemistry.

[14]  I. Luque,et al.  Structural stability of binding sites: Consequences for binding affinity and allosteric effects , 2000, Proteins.

[15]  Robert F. Boyko,et al.  Structure‐based thermodynamic analysis of the dissociation of protein phosphatase‐1 catalytic subunit and microcystin‐LR docked complexes , 2008, Protein science : a publication of the Protein Society.

[16]  C Cambillau,et al.  Model of a complex between the tetrahemic cytochrome c3 and the ferredoxin I from Desulfovibrio desulfuricans (Norway strain) , 1988, Proteins.

[17]  P. Charifson,et al.  Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study. , 1997, Biochemistry.

[18]  K. P. Murphy,et al.  Evaluation of linked protonation effects in protein binding reactions using isothermal titration calorimetry. , 1996, Biophysical journal.

[19]  A Wlodawer,et al.  Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. , 1998, Annual review of biophysics and biomolecular structure.

[20]  A. Velázquez‐Campoy,et al.  HIV-1 protease inhibitors: enthalpic versus entropic optimization of the binding affinity. , 2000, Biochemistry.

[21]  A. Velázquez‐Campoy,et al.  Thermodynamic basis of resistance to HIV-1 protease inhibition: calorimetric analysis of the V82F/I84V active site resistant mutant. , 2000, Biochemistry.

[22]  J. Sturtevant,et al.  Thermodynamics of binding of mononucleotides to ribonuclease T1 , 1992 .

[23]  G Klebe,et al.  Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition. , 2001, Journal of molecular biology.

[24]  D. M. Simons,et al.  Structure-Based Design of Synthetic Azobenzene Ligands for Streptavidin , 1994 .

[25]  I. Luque,et al.  Structure‐based thermodynamic design of peptide ligands: Application to peptide inhibitors of the aspartic protease endothiapepsin , 1998, Proteins.

[26]  C. Pace,et al.  A helix propensity scale based on experimental studies of peptides and proteins. , 1998, Biophysical journal.

[27]  A. Velázquez‐Campoy,et al.  Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes. , 2002, Biochemistry.

[28]  E. Freire,et al.  Direct measurement of protein binding energetics by isothermal titration calorimetry. , 2001, Current opinion in structural biology.

[29]  E. Freire,et al.  Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin. , 1995, Journal of molecular biology.

[30]  A. Velázquez‐Campoy,et al.  Thermodynamic dissection of the binding energetics of KNI‐272, a potent HIV‐1 protease inhibitor , 2000, Protein science : a publication of the Protein Society.